公司资料
Evotec 股价、新闻与催化剂
- 股票代码:
- EVO
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Germany and listed in global markets with U
股票表现
1.65 USD (-3.80%)
收盘价
最后更新: 2026年10月1日
1.05B USD
市值
股价为何变动
截至 2026年10月1日，EVO 下跌 3.80%，收于 $1.65。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Evotec is a drug-discovery and development platform company that supports pharma partners with research services and collaborative programs.
所在地与行业分类
Headquartered in Germany and listed in global markets with U.S. access, Evotec sits in discovery infrastructure.
商业模式特征
The business combines service revenue, milestone economics, and collaborative drug-discovery partnerships.
生物医药行业定位
Evotec is part of the biotech R&D infrastructure layer, where partner demand and platform execution matter most.
未来催化剂
- Evotec's catalysts are discovery-partner deal flow, platform execution, and any asset monetization that improves the company’s capital structure. The market will watch whether the partnership engine can create more tangible value.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。